Arnuity Ellipta (Fluticasone Furoate) Inhaler
Generic Name: Fluticasone Furoate
Therapeutic Class: Inhaled Corticosteroid (ICS)
Indication: Maintenance treatment of asthma in adults and adolescents aged 12 years and older
Comprehensive Guide to Arnuity Ellipta for Asthma Control
Arnuity Ellipta is a once-daily inhaled corticosteroid designed for the long-term management of asthma. Containing fluticasone furoate, it works directly within the lungs to reduce airway inflammation, improve breathing, and lower the frequency of asthma symptoms when used consistently. It is available in strengths of 100 micrograms (mcg) and 200 micrograms (mcg) per inhalation.
Asthma is a chronic inflammatory condition of the airways characterised by variable airflow obstruction and bronchial hyperresponsiveness. According to the NHS overview of asthma, common symptoms include wheezing, shortness of breath, chest tightness and coughing. Long-term anti-inflammatory therapy with inhaled corticosteroids remains a cornerstone of asthma management in national and international guidelines.
Buying Arnuity Ellipta from LifePath Meds may offer a cost-effective solution for patients seeking convenient access to prescribed asthma medication while maintaining high pharmaceutical quality standards.
What Is Arnuity Ellipta Used For?
Arnuity Ellipta is indicated for the maintenance treatment of asthma in adults and adolescents aged 12 years and older. It is not intended for the immediate relief of acute asthma attacks or sudden bronchospasm.
In line with recommendations from the National Institute for Health and Care Excellence (NICE) asthma guideline, inhaled corticosteroids are recommended as first-line preventer therapy to reduce airway inflammation and prevent exacerbations. Regular daily use is essential for optimal asthma control.
How Arnuity Ellipta Works
Targeting Airway Inflammation
Fluticasone furoate is a potent inhaled corticosteroid that exerts anti-inflammatory effects within the bronchial mucosa. By binding to glucocorticoid receptors in airway cells, it suppresses the release of pro-inflammatory mediators such as cytokines and leukotrienes. This reduces swelling, mucus production and airway hyperresponsiveness.
Improving Lung Function
By decreasing airway inflammation over time, Arnuity Ellipta helps improve airflow and stabilise respiratory symptoms. Consistent daily use reduces the likelihood of asthma flare-ups and supports long-term disease control.
Not a Rescue Inhaler
Arnuity Ellipta does not provide rapid bronchodilation and should not be used to treat acute asthma symptoms. Patients should always have a short-acting bronchodilator available for emergency symptom relief as prescribed by their healthcare provider.
Key Benefits of Arnuity Ellipta
- Once-daily dosing for improved treatment adherence
- Reduction in airway inflammation
- Improved lung function and breathing control
- Lower risk of severe asthma exacerbations when used regularly
- Reduced systemic exposure compared with oral corticosteroids
The convenience of once-daily administration may enhance compliance, particularly in individuals who struggle with multi-dose regimens.
Arnuity Ellipta vs Flovent: Understanding the Differences
Both Arnuity Ellipta and Flovent are inhaled corticosteroid therapies containing fluticasone derivatives; however, there are notable distinctions.
Active Ingredient Formulation
Arnuity Ellipta contains fluticasone furoate, while Flovent contains fluticasone propionate. Fluticasone furoate demonstrates strong receptor affinity, contributing to prolonged anti-inflammatory activity.
Dosing Frequency
Arnuity Ellipta is administered once daily, providing 24-hour anti-inflammatory coverage. In contrast, Flovent products are generally taken twice daily for optimal control.
Inhaler Device
Arnuity Ellipta uses the Ellipta dry powder inhaler, designed for simplicity and ease of use. Flovent may be delivered via a metered-dose inhaler (HFA) or Diskus device, depending on formulation.
Treatment selection depends on clinical assessment, patient preference, and adherence considerations.
Dosage and Administration
Dry powder inhaler (Ellipta device)
The usual starting dose for adults and adolescents aged 12 years and older is 100 mcg once daily. In patients with more severe asthma, the dose may be increased to 200 mcg once daily according to medical advice.
Arnuity Ellipta should be taken at the same time each day to maintain consistent anti-inflammatory effect.
How to Use Arnuity Ellipta
- Slide the inhaler cover down until you hear a click to prepare the dose.
- Exhale fully away from the inhaler.
- Place the mouthpiece between your lips and form a tight seal.
- Inhale steadily and deeply through your mouth.
- Hold your breath for 3–4 seconds.
- Remove the inhaler and exhale slowly.
- Close the cover.
- Rinse your mouth with water and spit it out to reduce the risk of thrush.
Proper inhaler technique is essential for optimal drug delivery. Healthcare professionals should periodically review inhaler use.
Potential Side Effects and Safety Profile
Common Side Effects
- Headache
- Nasal congestion
- Upper respiratory tract infections
- Oropharyngeal candidiasis (oral thrush)
- Hoarseness or voice changes
Local Corticosteroid Effects
Inhaled corticosteroids may increase the risk of fungal infections in the mouth. Rinsing and spitting after inhalation significantly reduces this risk.
Serious Reactions
Hypersensitivity reactions are rare but may occur. Arnuity Ellipta should not be used by individuals allergic to fluticasone furoate or milk proteins.
Use During Pregnancy and Breastfeeding
Data regarding the use of fluticasone furoate during pregnancy are limited. Treatment should only be continued if the anticipated benefit outweighs potential risk. Maintaining asthma control during pregnancy is important, as poorly controlled asthma can lead to adverse maternal and fetal outcomes.
Breastfeeding mothers should consult their healthcare provider before initiating therapy, as it is not known whether fluticasone furoate is excreted in human milk.
Storage Instructions
Store Arnuity Ellipta at room temperature between 15°C and 30°C in its original foil packaging to protect against moisture. Once opened, the inhaler should be discarded after six weeks or when the dose counter reaches zero.
Buying Arnuity Ellipta Online
Purchasing Arnuity Ellipta online may offer cost savings. Medicines should only be obtained from licensed pharmacies requiring a valid prescription.
LifePath Meds provides access to regulated medications delivered conveniently to your home. Patients should consult their healthcare provider before purchasing medications internationally and ensure compliance with local import regulations.
Arnuity Ellipta Discounts and Savings Options
Cost considerations are important for long-term asthma management. Promotional discounts, subscription services and first-time buyer offers may help reduce the overall expense of therapy. For example, introductory discount codes such as Hello10 may provide savings on initial purchases.
